Editorial: Endomysial Antibodies for a No-Biopsy Diagnosis of Coeliac Disease-The Jury Is Still out. Authors' Reply

Stiliano Maimaris^{1

2}, Annalisa Schiepatti^{1

2}, Federico Biagi^{1

2}

Affiliations

¹ Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
² Istituti Clinici Scientifici Maugeri IRCCS, Gastroenterology Unit of Pavia Institute, Pavia, Italy.

Editorial

Stiliano Maimaris et al. Aliment Pharmacol Ther. 2025 Jul.

. 2025 Jul;62(2):222-223.

doi: 10.1111/apt.70234. Epub 2025 Jun 13.

Stiliano Maimaris^{1

2}, Annalisa Schiepatti^{1

2}, Federico Biagi^{1

2}

¹ Department of Internal Medicine and Medical Therapy, University of Pavia, Pavia, Italy.
² Istituti Clinici Scientifici Maugeri IRCCS, Gastroenterology Unit of Pavia Institute, Pavia, Italy.

No abstract available

References

1. M. G. Shiha and H. A. Penny, “Editorial: Endomysial Antibodies for a No‐Biopsy Diagnosis of Coeliac Disease—The Jury Is Still out,” Alimentary Pharmacology & Therapeutics 62, no. 2 (2025): 220–221.
1. S. Maimaris, A. Schiepatti, D. I. Conforme Torres, et al., “Biopsy‐Sparing Diagnosis of Coeliac Disease Based on Endomysial Antibody Testing and Clinical Risk Assessment,” Alimentary Pharmacology & Therapeutics 61, no. 11 (2025): 1794–1804.
1. N. R. Lewis and B. B. Scott, “Systematic Review: The Use of Serology to Exclude or Diagnose Coeliac Disease (a Comparison of the Endomysial and Tissue Transglutaminase Antibody Tests),” Alimentary Pharmacology & Therapeutics 24 (2006): 47–54.
1. B. B. Suh‐Lailam, K. W. Davis, and A. E. Tebo, “Immunoassays for the Detection of IgA Antibodies to Tissue Transglutaminase: Significance of Multiples of the Upper Limit of Normal and Inter‐Assay Correlations,” Clinical Chemistry and Laboratory Medicine 54 (2016): 257–264.
1. M. G. Shiha, A. Schiepatti, S. Maimaris, N. I. Nandi, H. A. Penny, and D. S. Sanders, “Clinical Outcomes of Potential Coeliac Disease: A Systematic Review and Meta‐Analysis,” Gut 73 (2024): 1944–1952.